OpenLegislation

Regulation 15 Transitional provision – directions: recommendations, guidelines and informationI1

England and Wales

(1)

Paragraph (3) applies where, before the relevant date, the Institute, in connection with the promotion of clinical excellence and the effective use of available resources in the health service, has been directed by the Secretary of Statef1 to—

(a)

develop guidelines providing advice on good practice in the management of such diseases and conditions as may be notified by the Secretary of State;

(b)

provide such information on the implementation of the Institute’s recommendations and guidelines to persons employed in activities connected with the health service as may be conducive to their efficiency in relation to that employment;

(c)

include in its recommendations and guidelines guidance on clinical audit criteria;

(d)

disseminate through an appropriate range of media its recommendations and guidelines to the health service and general public;

(e)

look into and consider, for the purpose of advising the Secretary of State with regard to possible improvements in the provision of health services and in the effective use of available resources, such matters as were notified to it by the Secretary of State;

(f)

consider all interventional procedures notified to it;

(g)

identify any interventional procedure notified to it for which an assessment by the Institute as to whether it is safe and efficacious for use in the health service is unnecessary;

(h)

identify any interventional procedure notified to it otherwise than by the Secretary of State for which a comprehensive review of the evidence is required to enable the Institute to evaluate the procedure for the purposes of its recommendations or guidelines; and to evaluate its safety and efficacy for the purposes of use in the health service, and issue guidance to the health service on the use of the procedure;

(i)

assess the extent to which any interventional procedure notified to the Institute, other than one for which an assessment by the Institute is unnecessary, is safe and efficacious for use in the health service, and issue guidance to the health service on the use of the procedure;

(j)

subject to the approval of the Secretary of State, consider, and, as appropriate, endorse guidance prepared by other bodies concerning the clinical benefits of health care interventionsf2 and good practice in the management of diseases and other conditions affecting health; or

(k)

exercise any similar function of the Secretary of State relating to the health service, other than a function referred to in paragraph (3) or regulations 16 to 23.

(2)

Paragraph (3) applies where, before the relevant date, the Institute, in connection with the promotion of excellence in public health provision and promotion and the effective use of resources available in the health service and other available public funds, has been directed by the Secretary of Statef3 to—

(a)

develop, maintain and disseminate an evidence-base for effective public health action on health improvement and the reduction of inequalities in health;

(b)

provide guidance on the development and setting of standards for public health and health promotion programmes and practice and support their implementation;

(c)

provide guidance on the means for improving the capability and capacity of organisations, systems and the wider public health workforce to deliver health improvement and reduce inequalities in health; or

(d)

disseminate through an appropriate range of media, the guidance described in sub-paragraphs (b) and (c).

(3)

Where this paragraph applies, on and after the relevant date, NICE must treat the direction as if the direction had been given by the Secretary of State—

(a)

in the case of a matter concerning or connected with the provision of NHS services, under regulation 5(2); or

(b)

in the case of a matter concerning or connected with the provision of public health services, under regulation 5(3).

Annotations

Commencement

I1

Reg. 15 in force at 1.4.2013, see reg. 1(2)

Footnotes

f1

See paragraphs 2(1), (3) and (4) of the Directions and Consolidating Directions to the National Institute for Health and Clinical Excellence 2005, signed on 31st March 2005 (the NICE 2005 Directions), as amended by the Directions to the National Institute for Health and Clinical Excellence 2007, signed on 13th March 2007 (the 2007 Directions), Further Directions to the National Institute for Health and Clinical Excellence 2009, signed on 30th April 2009 (the 2009 Directions), and the National Institute for Health and Clinical Excellence (Amendment) Directions 2012, signed on 30 th March 2012 (the 2012 Directions). Copies of the Directions can be obtained from the NICE Sponsor team, Quarry House, Quarry Hill, Leeds, LS2 7UE.

f2

See the Directions to Primary Care Trusts and NHS trusts in England concerning Arrangements for the Funding of Technology Appraisal Guidance from the National Institute for Clinical Excellence (NICE) which came into force on 1st July 2003 (the Funding Directions). The Funding Directions can be viewed at http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsand statistics/Legislation/DirectionsfromtheSecretaryofState/DH_4075685.

f3

See paragraph 2(2) of the NICE 2005 Directions.

Notes on the whole SI

Textual amendments

F1

Title substituted (1.2.2023) by The Health and Social Care Information Centre (Transfer of Functions, Abolition and Transitional Provisions) Regulations 2023 (S.I. 2023/98), reg. 1(2), Sch. para. 45(2) (with reg. 3)